Myeloproliferative disorders: the centrosome connection - PubMed (original) (raw)

Review

. 2005 Oct;19(10):1739-44.

doi: 10.1038/sj.leu.2403926.

Affiliations

Review

Myeloproliferative disorders: the centrosome connection

B Delaval et al. Leukemia. 2005 Oct.

Abstract

Some myeloproliferative disorders (MPD) result from a reciprocal translocation that involves the FGFR1 gene and a partner gene. The event creates a chimeric gene that encodes a fusion protein with constitutive FGFR1 tyrosine kinase activity. FGFR1-MPD is a rare disease, but its study may provide interesting clues on different processes such as cell signalling, oncogenesis and stem cell renewal. Some partners of FGFR1 are centrosomal proteins. The corresponding oncogenic fusion kinases are targeted to the centrosome. Constitutive phosphorylation at this site may perturbate centrosome function and the cell cycle. Direct attack at this small organelle may be an efficient way for oncogenes to alter regulation of signalling for proliferation and survival and get rid of checkpoints in cell cycle progression. The same effect might be triggered by other fusion kinases in other MPD and non-MPD malignancies.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources